Literature DB >> 10898979

Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

D N Burshtyn1, J Shin, C Stebbins, E O Long.   

Abstract

Killer cell immunoglobulin-like receptors (KIR) inhibit the cytotoxic activity of natural killer (NK) cells by recruitment of the tyrosine phosphatase SHP-1 to immunoreceptor tyrosine-based inhibition motif (ITIM) sequences in the KIR cytoplasmic tail [1]. The precise steps in the NK activation pathway that are inhibited by KIR are yet to be defined. Here, we have studied whether the initial step of adhesion molecule LFA-1-dependent adhesion to target cells was altered by the inhibitory signal. Using stable expression of an HLA-C-specific KIR in the NK cell line YTS [2] and a two-color flow cytometry assay for conjugate formation, we show that adhesion to a target cell expressing cognate HLA-C was disrupted by KIR engagement. Conjugate formation was abruptly interrupted by KIR within less than 5 minutes. Inhibition of adhesion to target cells was mediated by a chimeric KIR molecule carrying catalytically active SHP-1 in place of its cytoplasmic tail. These results suggest that other ITIM-bearing receptors, many of which have no known function, may regulate adhesion in a wide variety of cell types.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898979     DOI: 10.1016/s0960-9822(00)00568-6

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  35 in total

1.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

2.  Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact.

Authors:  Jonathan Back; Anick Chalifour; Léonardo Scarpellino; Werner Held
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

3.  JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Authors:  Changlin Li; Baoxue Ge; Matthew Nicotra; Joel N H Stern; Hernan D Kopcow; Xi Chen; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

Review 4.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 5.  Mechanisms and functions for the duration of intercellular contacts made by lymphocytes.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2009-07-17       Impact factor: 53.106

6.  Quantitative measurement of F-actin accumulation at the NK cell immunological synapse.

Authors:  Pinaki P Banerjee; Jordan S Orange
Journal:  J Immunol Methods       Date:  2010-02-19       Impact factor: 2.303

7.  Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization.

Authors:  Catharina C Gross; Joseph A Brzostowski; Dongfang Liu; Eric O Long
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

Review 8.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 9.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

10.  Natural killer cell signal integration balances synapse symmetry and migration.

Authors:  Fiona J Culley; Matthew Johnson; J Henry Evans; Sunil Kumar; Rupert Crilly; Juan Casasbuenas; Tim Schnyder; Maryam Mehrabi; Mahendra P Deonarain; Dmitry S Ushakov; Veronique Braud; Günter Roth; Roland Brock; Karsten Köhler; Daniel M Davis
Journal:  PLoS Biol       Date:  2009-07-28       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.